Suppr超能文献

一步法核酸扩增检测头颈部鳞状细胞癌的淋巴结转移。

One-step nucleic acid amplification for detecting lymph node metastasis of head and neck squamous cell carcinoma.

机构信息

Head Neck Surgery Department, University Hospital, Rennes, France.

Department of Biology, Eugène Marquis Comprehensive Cancer Center, CS 44 229, Av. De Bataille Flandres Dunkerques, 35042 Rennes Cedex, France.

出版信息

Oral Oncol. 2020 Mar;102:104553. doi: 10.1016/j.oraloncology.2019.104553. Epub 2020 Jan 28.

Abstract

BACKGROUND

In head and neck squamous cell carcinoma (HNSCC) 30% of cN0 patients have occult metastasis. LN invasion is a major prognostic factor. Sentinel lymph node (SLN) is an option for cN0 neck management. One-step nucleic acid amplification (OSNA) used to analyze SLN in breast cancer is also a candidate to get more reliable intraoperative HNSCC lymph node (LN) staging.

OBJECTIVE

To compare OSNA analysis to pathological analysis in cN0 HNSCC.

MATERIALS AND METHODS

157 LN from 26 cN0 HNSCC patients were prospectively analyzed (6.3LN/patient). Exclusion criteria were previous surgery or radiotherapy. Each node was cut into 4 equal pieces alternatively sent to pathological analysis and OSNA technique. IHC CK19 was performed on the primary tumor biopsy and RT-qPCR of CK19, PVA and EPCAM on the LN lysate of discordant cases.

RESULTS

OSNA was able to provide intraoperative result in all patients. OSNA detected 21 metastases. There were 139 concordant LN (88.5%). There were 18 initial discordant LN (11.5%), 13 (8.3%) were OSNA positive/pathological analysis negative, 5 (3.2%) were OSNA negative/pathological analysis positive. After elimination of allocation bias, false negative rate was 1.3%, sensitivity and specificity were 90% and 95.6%, PPV and NPV were 75% and 98.5%.

CONCLUSION

Our results suggest that OSNA should be considered to improve SNB analysis both for increasing micro metastasis diagnosis and offer extemporaneous results. Study registered under clinicaltrials.gov database number NCT02852343.

摘要

背景

在头颈部鳞状细胞癌(HNSCC)中,30%的 cN0 患者存在隐匿性转移。LN 侵犯是主要的预后因素。前哨淋巴结(SLN)是 cN0 颈部管理的一种选择。用于分析乳腺癌 SLN 的一步法核酸扩增(OSNA)也是获得更可靠的 HNSCC 淋巴结(LN)分期的术中方法的候选方法。

目的

比较 OSNA 分析与 cN0 HNSCC 的病理分析。

材料和方法

前瞻性分析了 26 例 cN0 HNSCC 患者的 157 个 LN(每个患者 6.3 个 LN)。排除标准为既往手术或放疗。每个淋巴结切成 4 等份,分别用于病理分析和 OSNA 技术。对原发性肿瘤活检进行 IHC CK19,对不一致病例的 LN 裂解物进行 RT-qPCR CK19、PVA 和 EPCAM。

结果

OSNA 能够为所有患者提供术中结果。OSNA 检测到 21 个转移灶。有 139 个 LN (88.5%)一致。有 18 个初始不一致的 LN(11.5%),13 个(8.3%)是 OSNA 阳性/病理分析阴性,5 个(3.2%)是 OSNA 阴性/病理分析阳性。消除分配偏差后,假阴性率为 1.3%,灵敏度和特异性分别为 90%和 95.6%,PPV 和 NPV 分别为 75%和 98.5%。

结论

我们的结果表明,OSNA 应该被考虑用于改善 SNB 分析,以提高微转移的诊断,并提供即时结果。该研究在 clinicaltrials.gov 数据库中注册,编号为 NCT02852343。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验